Mark R Dowling Melbourne Immunotherapy Spring Symposium 2025

Abstracts this author is presenting:

• Circulating tumour DNA-directed consolidation with epcoritamab alone or in combination with lenalidomide and rituximab is feasible in the early post-CAR-T population at high risk of relapse: preliminary results from EpLCART — Poster Session